Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic experiments, and makes sure security in study, enhancing reproducibility and advancing growing old and oncology investigations. Daily laboratory workflows usually expose gaps where existing compounds are unsuccessful to address mobile senescence comp